Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity. |
1989 |
Transplantation |
pmid:2465592
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. II. Inhibition of the production of IL-2 and gamma-IFN, but not B cell-stimulating factor 2. |
1989 |
Transplantation |
pmid:2465593
|
Thomson AW |
FK-506--how much potential? |
1989 |
Immunol. Today |
pmid:2473767
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Ochiai T et al. |
Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs. |
1989 |
Transplantation |
pmid:2474209
|
Siekierka JJ et al. |
FK-506, a potent novel immunosuppressive agent, binds to a cytosolic protein which is distinct from the cyclosporin A-binding protein, cyclophilin. |
1989 |
J. Immunol. |
pmid:2474605
|
McCauley J et al. |
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. |
1989 Dec 23-30 |
Lancet |
pmid:2481200
|
Collier SJ |
Immunosuppressive drugs. |
1989-1990 |
Curr. Opin. Immunol. |
pmid:2484794
|
Staschak S et al. |
A cost comparison of liver transplantation with FK 506 or CyA as the primary immunosuppressive agent. |
1990 |
Transplant. Proc. |
pmid:1689896
|
Starzl TE et al. |
Kidney transplantation under FK 506. |
1990 |
JAMA |
pmid:1693970
|